Author

Meili Ding

Observed name: Ding, Meili

Institution: Binzhou People's Hospital

Observed institutions: Shihezi University, Binzhou People's Hospital, First Affiliated Hospital of Shihezi University Medical College, Jining First People's Hospital

ORCID: 0000-0002-0095-3667

Observed ORCID: 0000-0002-0095-3667

OpenAlex ID: A5035814631

Retracted: MicroRNA‐31 weakens cisplatin resistance of medulloblastoma cells via NF‐κB and PI3K/AKT pathways

2020 · Hui Ma, Wei Cao, et al. · BioFactors · 11

SR-B1 and CD10 combined immunoprofile for differential diagnosis of metastatic clear cell renal cell carcinoma and clear cell carcinoma of the ovary

2021 · Teng Jiang, Xiaoli Diao, et al. · Journal of Molecular Histology · 8

Exome sequencing analysis of gastric primary myeloid sarcoma with monocytic differentiation with altered immunophenotype after chemotherapy: case report

2023 · Xiang Li, Hongxia Zhang, et al. · Diagnostic Pathology · 5

A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature review

2024 · Ruiqi Zhang, Meili Ding, et al. · Diagnostic Pathology · 4

Correction: Exome sequencing analysis of gastric primary myeloid sarcoma with monocytic differentiation with altered immunophenotype after chemotherapy: case report

2023 · Xiang Li, Hongxia Zhang, et al. · Diagnostic Pathology · 1

Works count: 7

Citation count: 29

H-index: 4

I10-index: 1